Tiziana Life Sciences October 26, 2020 – Posted in: Tiziana Life Sciences (TILS)

26th October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Exercise of options, Issue of Equity PDMR Dealing and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 329,225 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of…

(No title) October 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

21st October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Exercise of options, Issue of Equity PDMR Dealing and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued total of 1,750,000 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid; (i) in…

Tiziana Life Sciences – Issue of Equity on Exercise of Warrants October 20, 2020 – Posted in: Tiziana Life Sciences (TILS)

20th October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Issue of Equity on Exercise of Warrants Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 35,714 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of 70 pence per share in…

Tiziana Life Sciences – Issue of Equity & Total Voting Rights September 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

21st September, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Issue of Equity and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 281,250 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of 128 pence per share in…

Tiziana Life Sciences (TILS)- Issue of Equity August 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Monday 3rd August, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million New York and London, August 3, 2020 – Tiziana Life Sciences plc (NASDAQ: TLSA; AIM: TILS) (the “Company” or “Tiziana”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announced it has entered into definitive agreements with investors for the purchase and sale of 11,009,615 of the Company’s American Depositary Shares…

Tiziana Life Sciences – Exercise of Warrants & Issue of Equity & Total Voting Rights July 24, 2020 – Posted in: Uncategorized

24th July, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Exercise of Warrants and Issue of Equity and Total Voting Rights London, New York, 24 July 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 88,580 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid in respect of…

Tiziana Life Sciences plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 22, 2020 – Posted in: Tiziana Life Sciences (TILS)

Monday 22nd June, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Exercise of Warrants and Issue of Equity and Total Voting Rights London, New York, 22 June 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has allotted and issued 1,800,000 ordinary shares of 3 pence each (“New Ordinary Shares”)…

Tiziana Life Sciences Plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences plc (“Tiziana” or the “Company”) Correction – Exercise of Warrants and Issue of Equity and Total Voting Rights The announcement (RNS Number: 6069O) released on 2 June 2020 at 07:00 am stated that 1,498,685 new ordinary shares will be issued yielding £710,843 in cash proceeds, the announcement should have stated the number of shares to be issued is 1,234,399, yielding £578,700 cash proceeds. All other details in the announcement remain unchanged. The amended announcement is set out below:…

Tiziana Life Sci (TILS) Issue of Equity and Directorate Change November 20, 2019 – Posted in: Tiziana Life Sciences (TILS)

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. New York/London, 20 November 2019 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that it has issued 190,698 ordinary shares of 3p each (“Ordinary Shares”) credited as fully paid at a price of 43p per share in satisfaction of a…